1 Min Read
* Zomedica Pharmaceuticals Corp announces third quarter 2016 financial results
* Q3 loss per share $0.01
* Expects G&A expenditures throughout 2016 will be higher as compared to same periods in 2015 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.